FDA Inspection
Hikma Pharmaceuticals USA, Inc.Hikma Pharmaceuticals USA, Inc. – FDA Inspection, Jul 7, 2016
Record Details
This FDA Inspection record concerns Hikma Pharmaceuticals USA, Inc., with an inspection on July 7, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 7, 2016
- Product Type
- Drugs
View Company Profile
ID · a39d289b-eef3-401a-b2ac-d25f0be87c2b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 976090
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Hikma Pharmaceuticals USA, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| February 1, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 13, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 10, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 26, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2013 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hikma Pharmaceuticals USA, Inc.
- FDA Inspection 1079961 - 2019-02-01
- FDA Inspection 1054739 - 2018-04-13
- FDA Inspection 942928 - 2015-09-10
- FDA Inspection 864847 - 2014-02-26
- FDA Inspection 829253 - 2013-06-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.